Generation Bio Co. financial data

Symbol
GBIO on Nasdaq
Location
301 Binney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 711 % -42.4%
Debt-to-equity 112 % +114%
Return On Equity -105 % -122%
Return On Assets -49.5 % -59.4%
Operating Margin -846 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66.8M shares +1.08%
Common Stock, Shares, Outstanding 66.8M shares +1.25%
Entity Public Float 299M USD -2.16%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 66.7M shares +1.26%
Weighted Average Number of Shares Outstanding, Diluted 66.7M shares +1.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 18.6M USD +252%
Research and Development Expense 73.7M USD -15.5%
General and Administrative Expense 42.5M USD -15.9%
Operating Income (Loss) -157M USD -16.6%
Nonoperating Income (Expense) 11.8M USD +7.06%
Net Income (Loss) Attributable to Parent -145M USD -17.5%
Earnings Per Share, Basic -2.19 USD/shares -10.6%
Earnings Per Share, Diluted -2.19 USD/shares -10.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.7M USD -76.8%
Marketable Securities, Current 163M USD -17.5%
Accounts Receivable, after Allowance for Credit Loss, Current 2.21M USD
Other Assets, Current 290K USD +12%
Assets, Current 191M USD -35.8%
Property, Plant and Equipment, Net 16M USD -28.5%
Operating Lease, Right-of-Use Asset 21.2M USD -61%
Other Assets, Noncurrent 3.11M USD +304%
Assets 249M USD -34.8%
Accounts Payable, Current 1.66M USD -37.4%
Employee-related Liabilities, Current 4.51M USD -22.4%
Contract with Customer, Liability, Current 5.68M USD
Liabilities, Current 30.2M USD -8.09%
Contract with Customer, Liability, Noncurrent 55.1M USD
Operating Lease, Liability, Noncurrent 83M USD +16.9%
Liabilities 144M USD -3.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 319K USD
Retained Earnings (Accumulated Deficit) -682M USD -27.1%
Stockholders' Equity Attributable to Parent 104M USD -55%
Liabilities and Equity 249M USD -34.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.7M USD -14.5%
Net Cash Provided by (Used in) Financing Activities -125K USD -100%
Net Cash Provided by (Used in) Investing Activities -553K USD +90.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 66.8M shares +1.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.8M USD -76%
Deferred Tax Assets, Valuation Allowance 176M USD +27.3%
Operating Lease, Liability 62M USD
Payments to Acquire Property, Plant, and Equipment 1.92M USD +154%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -145M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid 137M USD +31.1%
Property, Plant and Equipment, Gross 38.3M USD -6.2%
Operating Lease, Liability, Current 10.8M USD +23.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.6M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.2M USD +13.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.9M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.1M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 96.9M USD +8.26%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.6M USD +2.83%
Operating Lease, Payments 1.9M USD -38.7%
Additional Paid in Capital 786M USD +2.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.15M USD -2.24%
Deferred Tax Assets, Net of Valuation Allowance 198M USD +25.3%
Share-based Payment Arrangement, Expense 17.5M USD -27.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%